PV Bulletin

Pharmatech MK-677 Capsules: Undisclosed Anabolic Steroid Found

TGA safety alert: Pharmatech-branded MK-677 capsules found to contain undeclared metandienone, an anabolic steroid with serious health risks.

PV Impact Brief

Urgency: HighConfidence: high

What changed

TGA issued a safety alert on 4 June 2026 after lab testing found undeclared metandienone in Pharmatech MK-677 capsules.

Why it matters

Metandienone is an anabolic steroid with known serious adverse effects; its undisclosed presence poses significant health risks to consumers.

Action needed

Stop using and dispose of Pharmatech MK-677 capsules immediately; consult a healthcare professional if concerned.

Relevant for
Regulatory Intelligence LeadSignal Management Lead
Processes impacted
Signal ManagementLabeling
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Regulatory action details

Action type
Safety Alert
Publication date
2026-06-04
Safety issue
Laboratory testing of 'Pharmatech' branded MK-677 capsules (containing ibutamoren) found that the capsules contained undeclared metandienone (an anabolic steroid). Metandienone can cause serious health risks including liver damage and cardiovascular issues.

Affected products

  • MK-677 capsules
    Pharmatech

PV internal implications

Stop using the capsules immediately. Consult a medical professional if you have concerns. Dispose of any remaining product.

View regulator source

Evidence and confidence

Confidence: highSource updated: Jun 4, 2026

Full briefing

Practical implication

Stop using and dispose of Pharmatech MK-677 capsules immediately; consult a healthcare professional if concerned.

Laboratory testing of Pharmatech MK-677 capsules (containing ibutamoren) revealed undeclared metandienone, an anabolic steroid that can cause liver damage and cardiovascular issues. TGA advises immediate cessation of use and disposal of remaining product.

What changed: TGA issued a safety alert on 4 June 2026 after lab testing found undeclared metandienone in Pharmatech MK-677 capsules.

Why it matters: Metandienone is an anabolic steroid with known serious adverse effects; its undisclosed presence poses significant health risks to consumers.

Practical implication: Stop using and dispose of Pharmatech MK-677 capsules immediately; consult a healthcare professional if concerned.

View original source

Published from the Firecrawl agent regulatory extraction pipeline.

Related updates for your role

publicFood and Drug Administration (FDA) · United States · Updated Jun 29, 2026

eMDR System Enhancements - Production Deployment

Urgency: High

Update electronic safety reporting systems and pharmacovigilance databases to implement new rules to ensure all submissions use GENC 3-letter country codes and include the required fields as of July 20, 2026.

ICSRCountry ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, QPPV
verifiedRegulatory action: Notice
Read impact briefarrow_forward
publicTherapeutics Goods Administration · Australia · Updated Jul 20, 2026

Updates on ISO 14155 and N=1 Therapeutics Discussed by TGA

Urgency: High

Investigators need to modify trial protocols and safety reporting mechanisms in line with the latest ISO 14155 updates to ensure compliance for upcoming high-risk clinical trials.

Inspection ReadinessICSRRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, PV Quality Lead
verifiedRegulatory action: Notice
Read impact briefarrow_forward
publicEuropean Medicines Agency (EMA) · European Union · Updated Jul 20, 2026

CHMP Draft Agenda for Public Consultation on Thalassaemia and Sickle Cell Disease Guidelines

Urgency: High

Sponsors and MAHs must review and align safety data collection and reporting protocols with the newly adopted guidelines while preparing for implementation of PRAC recommendations stemming from this meeting.

Signal ManagementICSRRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead
verifiedRegulatory action: Agenda
Read impact briefarrow_forward
publicSwissmedic · Switzerland · Updated Jul 17, 2026

Checklist for the Inspection of Medical Device Vigilance in Hospitals

Urgency: High

Healthcare facilities must utilize the new checklist during inspections to conduct gap analyses and ensure compliance with reporting requirements associated with their vigilance systems.

Inspection ReadinessRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, PV Quality Lead
verifiedRegulatory action: Checklist
Read impact briefarrow_forward